Physician profile
Olivia M Covert
NPI 1598298556
$7,158.45
in general payments reported to CMS, 2019-2025
33 companies · $1,861 in 2025
The $1,861 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,140 · 2022: $1,291 · 2023: $1,500 · 2024: $1,367 · 2025: $1,861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,727.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $755.94 | 2021-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Rivacor 7 Dr-T |
| Janssen Pharmaceuticals, INC | $708.86 | 2021-2024 | Xarelto |
| Medtronic, INC. | $678.10 | 2022-2025 | Affera Mapping System, Linq II, Aurora Ev-Icd Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $568.03 | 2021-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $561.16 | 2021-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $519.72 | 2021-2025 | Lifevest |
| Pfizer INC. | $360.94 | 2021-2025 | |
| Abbott Laboratories | $348.65 | 2021-2024 | Amplatzer Amulet, Confirm Rx, Gallant |
| Impulse Dynamics (USA) INC. | $348.10 | 2023-2025 | Optimizer, Optimizer |
| Atricure, INC. | $340.01 | 2023-2024 | |
| Boston Scientific Corporation | $321.30 | 2021-2024 | Latitude Communicator Power Supply, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Merck Sharp & Dohme LLC | $256.90 | 2021-2023 | Verquvo |
| Amgen INC. | $241.61 | 2021-2024 | Repatha |
| Philips North America LLC | $206.59 | 2025 | Ecc Solutions |
| Kiniksa Pharmaceuticals, LTD. | $103.95 | 2021-2023 | Arcalyst |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $89.31 | 2021-2023 | |
| Cvrx, INC. | $84.33 | 2021-2024 | Barostim Neo System |
| Novo Nordisk INC | $78.21 | 2024-2025 | Wegovy |
| Vital Connect, INC | $72.92 | 2024-2025 | Vitalpatch Rtm |
| Scpharmaceuticals INC. | $59.80 | 2023-2025 | |
| Cardiva Medical, INC. | $58.47 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $55.46 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $50.82 | 2024 | Arcalyst |
| Becton, Dickinson and Company | $42.20 | 2025 | Hemosphere |
| United Therapeutics Corporation | $37.60 | 2021 | |
| Baxter Healthcare | $32.60 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $32.52 | 2023 | Andexxa |
| Shockwave Medical, INC | $31.95 | 2025 | |
| Alnylam Pharmaceuticals INC. | $31.03 | 2022-2023 | Onpattro |
| Edwards Lifesciences Corporation | $26.41 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.74 | 2025 | |
| Xeris Pharmaceuticals, INC. | $20.32 | 2023 | Keveyis |
| Lexicon Pharmaceuticals, INC. | $13.90 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Covert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.